title: Pioglitazone causing urinary bladder cancer? While waiting for the result of the debate, suggestions for physicians.
authors.forename: Eylem
authors.initials: E
authors.lastname: Cagiltay
authors.forename: Tolga
authors.initials: T
authors.lastname: Tuncel
authors.forename: Arif
authors.initials: A
authors.lastname: Yönem
authors.forename: Gökhan
authors.initials: G
authors.lastname: Ozdemir
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D000077205:Pioglitazone; D011379:Prognosis; D012307:Risk Factors; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use; D014421:Turkey / Q000453:epidemiology; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone